Zhitong Financial and Economic APP News, Shenlian Biology (688098.SH) issued a notice that the company recently passed the supervision and inspection of the veterinary drug clinical trial quality management standard (GCP) of the Animal Husbandry and Veterinary Bureau of the Ministry of Agriculture and villages.

According to the announcement, there are two supervision and inspection projects of the veterinary drug clinical trial quality management standard (GCP) of the Animal Husbandry and Veterinary Bureau of the Ministry of Agriculture and villages, which indicates that the company has the clinical trial qualification to carry out the safety and effectiveness of veterinary biological products in pigs, which has laid a solid foundation for the rapid promotion of the company's new product research and development project. At the same time, it marks the company's standardized innovation and evaluation of veterinary drugs to a new level, which is the result of the company's continuous attention to R & D investment for many years, and will further improve the company's R & D strength and core competitiveness. it will have a positive impact on the implementation of diversified development strategy for the company.